A Study to Assess the Safety and Pharmacokinetics of AD-104-A
Clinical trial NCT05703282 · COMPLETED
Trial details
- NCT number
- NCT05703282
- Sponsor
- Addpharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2024-04-05
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.